The complete range of services for Prototyping and maintenance in Medicine & Pharmaceuticals
Long experience of scientific research in the field of molecular biology. I can give advice on the development of new products.
Condition optionsThe task is to develop an algorithm for separating deviations into those caused by the operation of the equipment and those caused by a malfunction of the sensors. An expert in the field will be provided to help.
Condition optionsSubject matter expert with experience in health services research, pharmaceutical and health policies.
Condition optionsTechnical due diligence, startup strategy developing, preclinical study design, etc. Wide experience in building innovative preclinical research programs to investigate neurological, metabolic, and inflammatory diseases as well as experience in early stage biotechnology R&D.
Condition optionsHi all! I am looking for co-authors to jointly write textbooks on medicine and pharmacology. I am a Ph.D., area of interest: biological properties of coordination compounds of silver and tryptophan.
Condition optionsThis lectures will cover algorithms for solving various biological problems along with a handful of programming challenges helping you implement these algorithms in Python. Lectures will be read by a professor, and practical classes will be conducted by a specialist from the Department of Computer Science.
Condition optionsKorean native language, knowledge of English - C1. Ph.D. in medical sciences, broad knowledge in medicine and pharmacology. 4 textbooks have been published, including 2 international ones.
Condition optionsWe are a biotech startup which focuses on manufacturing surgical robots. These surgical robots are being developed with the goal to enable minimally invasive treatments with high precision. Some of their main use cases are treatment of cancer cells in order to halt the progression of the disease. Now we are entering the market and we need highly targeted advertising, which will tell about our developments and will attract investors.
Condition options